RxDoctor Payments Data

Hayden Pasco, MD

Family Medicine · Midlothian, VANPI 1578724274

Payments from drug & device makers

$4,060in general payments, 2019–2025

Across 248 payments — averaging $16.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$864
  • Novo Nordisk$577
  • Amgen$550
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$299
  • Lilly USA, LLC$275
  • Novartis$176
  • plus $1K from 26 others

What the payments were for

  • Food & beverage$4,03299%
  • Education$281%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,060 in reported general payments places this provider in the 85th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$24,522
Medicare patients
65
Services billed
260

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide12$33,295
Repatha SureclickEvolocumab25$28,627
Repatha PushtronexEvolocumab27$18,249
TrintellixVortioxetine Hydrobromide21$12,161
SynthroidLevothyroxine Sodium24$1,304
Rosuvastatin Calcium132$1,293
Estradiol14$1,115
Celecoxib13$928
Levothyroxine Sodium44$411
Hydrocortisone11$351
Gabapentin17$321
Lisinopril24$316
Trazodone Hcl26$294
ValacyclovirValacyclovir Hcl11$278
Escitalopram Oxalate13$208

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$577$33,29512 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$99$12,16121 claims
AbbVieSynthroid$864$1,30424 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Midlothian

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →